original articleshematologic malignanciesGemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
hematologic malignancies
Under an Elsevier user license
open archive
Keywords
gemcitabine
Hodgkin's lymphoma
liposomal doxorubicin
recurrent
salvage therapy
vinorelbine
Cited by (0)
N. L. Bartlett designed research, performed research, analyzed data, and wrote the paper; D. Niedzwiecki designed research and analyzed data; J. L. Johnson designed research, collected data, and analyzed data; J. W. Friedberg treated significant proportion of patients on trial and edited the paper; K. B. Johnson treated significant proportion of patients on trial and edited the paper; K. van Besien treated significant proportion of patients on trial and edited the paper; A. D. Zelenetz designed research; B. D. Cheson edited the paper; and G. P. Canellos designed research and edited the paper.
Copyright © 2007 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.